Subscribe To
Why these 3 stocks are the worst ways to play biotech right now
The tech and growth segments of the market have been having a tremendous 2023 with one glaring exception. Traders have been choosing to avoid ...
July 13, 2023, 7:31 am
3 biotech stocks to buy for long-term gains
Suppose you're looking for a sector that will benefit from an end to the Federal Reserve's interest rate hiking campaign. In that case, you may look a...
July 13, 2023, 7:01 am
Nvidia and recursion pharmaceuticals team up on ai-based biotech collaboration
Tech giant NVIDIA Corporation (NASDAQ:NVDA) has dedicated US$50mln to a multi-year collaboration with US-listed ...
July 13, 2023, 3:21 am
3 biotech stocks to sell before they damage your portfolio
There are several reasons that investors should be cautious about buying or holding biotech stocks at t...
July 12, 2023, 5:33 pm
Rxrx stock: nvidia investment sends recursion pharmaceuticals soaring
Confirming the ongoing fervor for all things artificial intelligence (AI), shares of biotechnology firm Recursion Pharmaceuticals (NASDAQ: RXRX ) are ...
July 12, 2023, 3:33 pm
Recursion pharmaceuticals soars 121% after nvidia invests $50 million in the biotech for ai drug discovery
Recursion Pharmaceuticals stock soared as much as 121% on Wednesday after it received an investment from Nvidia. Nvidia said it would invest $50 milli...
July 12, 2023, 3:06 pm
Nvidia invests $50 million in biotech company recursion for ai drug discovery
Nvidia is investing in Recursion, which uses AI models to identify new therapies and offers those models to its partners, including Roche and Bayer....
July 12, 2023, 2:42 pm
Is now the right time to embrace biotech etfs?
Look if it's the right time to invest in biotech ETFs to help diversify your portfolio....
July 12, 2023, 12:34 pm
Recursion pharmaceuticals stock soars on nvidia investment in ai
Recursion Pharmaceuticals Inc shares surged 64% to $11.09 in late-morning trading on Wednesday after NVIDIA Corp announced it is making a $50 million ...
July 12, 2023, 11:41 am
Eu fines illumina record $476 million for closing grail deal without approval
The European Commission fined biotech firm Illumina 432 million euros ($476 million) for closing its ac...
July 12, 2023, 9:40 am
Nvidia invests $50 million in biotech company for ai drug discovery
Recursion Pharmaceuticals stock has gained more than 150%....
July 12, 2023, 9:05 am
Nvidia invests $50 mln in recursion to train ai models for drug discovery
Nvidia invested $50 million to speed up training of biotech firm Recursion's artificial intelligence mo...
July 12, 2023, 8:31 am
3 biotech stocks that ai is loving in july
Artificial intelligence (AI) has become an invaluable tool for investors seeking opportunities in the stock market. Its ability to analyze large amoun...
July 12, 2023, 7:51 am
Why these 7 stocks are the best ways to play biotech right now
Best biotech stocks represents a concept that, no matter what, the market cycle fundamentally delivers ...
July 11, 2023, 8:53 pm
Ixj: potential to generate steady price growth over the long run
As the populations of most wealthy countries continue to age, the healthcare sector is going to benefit irrespective of economic conditions. Investors...
July 11, 2023, 5:54 pm
We've only seen the beginning of moderna's story, says goldman sachs' salveen richter
Salveen Richter, Goldman Sachs lead biotech analyst, joins 'Closing Bell Overtime' to discuss the ...
July 11, 2023, 5:42 pm
Why these 2 nasdaq biotech stocks fell hard tuesday morning
Futures on the Nasdaq inched higher Tuesday morning. Viridian fell despite announcing some favorable early results from a clinical trial....
July 11, 2023, 9:26 am
Nautilus biotechnology to announce second quarter financial results on august 2, 2023
SEATTLE, July 11, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule prot...
July 11, 2023, 9:23 am
Maxim upbeat on atossa therapeutics after recent updates
Analysts at Maxim Group have reiterated a 'buy' rating on Atossa Therapeutics Inc (NASDAQ:ATOS) shares after the ...
July 11, 2023, 8:06 am
Allovir: 'takes one to know one'
Gilead has purchased $10.9 million in shares of Allovir, a biotech company specializing in cell therapy...
July 10, 2023, 7:13 pm